Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects

NCT02074995 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped The study was prematurely terminated due to recruitment issues

Conditions

Hypercatabolic Status Related to Severe Burn

Interventions

BIOLOGICAL: BVS857
OTHER: placebo

Sponsor

Novartis Pharmaceuticals